Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
US8247415B2 · kind B2 · utility
28Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2009 |
| Grant date | Aug 21, 2012 |
| Priority date | — |
| Expiry date | Dec 1, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.